Characterization of Influenza Hemagglutinin Mutants for the Elucidation of Key Residues’ Effect on Activation by Baltz, Morgan
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
University of Tennessee Honors Thesis Projects University of Tennessee Honors Program
5-2013
Characterization of Influenza Hemagglutinin
Mutants for the Elucidation of Key Residues’ Effect
on Activation
Morgan Baltz
mbaltz@utk.edu
Follow this and additional works at: https://trace.tennessee.edu/utk_chanhonoproj
Part of the Biochemical and Biomolecular Engineering Commons
This Dissertation/Thesis is brought to you for free and open access by the University of Tennessee Honors Program at Trace: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in University of Tennessee Honors Thesis Projects by an authorized administrator of Trace:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.
Recommended Citation
Baltz, Morgan, "Characterization of Influenza Hemagglutinin Mutants for the Elucidation of Key Residues’ Effect on Activation"
(2013). University of Tennessee Honors Thesis Projects.
https://trace.tennessee.edu/utk_chanhonoproj/1609
  
Characterization of Influenza Hemagglutinin Mutants for 
the Elucidation of Key Residues’ Effect on Activation 
 
 
 
 
University of Tennessee, Knoxville 
Chemical and Biomolecular Engineering Department 
 
 
 
Morgan R. Baltz 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Table of Contents 
 
 
Abstract……………………………………………………………………3 
 
Introduction……………………………….......………………………….3 
 
Background……………………..………………………………………...5 
 
Cell-Based Detection Assay to Identify Novel Activators………...6 
 
Characterization of Single Mutants……………………………........10 
 
Materials and Methods………………………………….……………..11 
 
Results……………………………………………………………………13 
 
Conclusions……………………………………………………………..15 
 
References……………………………………………………………….18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Abstract 
 
       Hemagglutinin (HA) is a viral fusion protein that undergoes an irreversible 
conformational change upon acidification to catalyze the fusion of endosomal 
and viral membranes.  Previous work utilized directed evolution to identify novel 
mutants with activation pH across a range of 4.8-6.0; wild-type HA activates 
around pH 5.2. This work further evaluates these mutants by analyzing individual 
amino acid substitutions and has identified point mutants responsible for 
phenotypic changes, thus providing additional structure-function insight. In most 
of the novel mutants analyzed, single mutations providing either a stabilizing or 
destabilizing effect were found to solely elicit the novel activation pH. Mutant 
HA3.2.5, however, activates at pH 5.6 through the combined effect of both 
stabilizing and destabilizing mutations. 
 
Introduction 
 
 There is currently a push towards the advancement of “personalized 
medicine”, in which individual genetic differences guide the detection, diagnosis, 
and treatment of patients. It is these incredibly minute individual genetic 
differences that can lead to drastic variation in disease progression, and most 
critically, in the patient response to pharmaceuticals. One major impediment to 
the progression of personalized medicine, however, is the development of 
specific and efficient drug delivery mechanisms.  
 Viruses have naturally evolved as an efficient delivery mechanism, 
possessing the ability to recognize specific cell targets, gain entry into the host 
cell, and then utilize cell machinery for their own propagation. The study of these 
viral mechanisms advances knowledge of viruses themselves, but also provides 
a foundation for which new drug delivery systems can be engineered. Of 
particular interest is influenza hemagglutinin, a membrane protein which assists 
with the initial viral binding event, as well as mediating fusion between the viral 
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and endosomal membranes, which enables the release of the viral genome into 
the host cell (Figure 1) 
 
 
Figure 1: Influenza virus life cycle.  
Mark von Itzstein, Nature Reviews: Drug Discovery , 6 (2007), 967-974. 
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Background 
 
 Influenza hemagglutinin (HA) is a membrane glycoprotein presented as a 
homotrimer of heterodimers. It is synthesized as a single polypeptide chain, HA0, 
which is protolytically cleaved into two subunits, HA1 and HA2, which remain 
associated via a disulfide bond.1-3  
The N-terminus of HA2 contains 20 highly conserved, hydrophobic 
residues called the “fusion peptide”4 . At neutral pH, this fusion peptide remains 
buried in the trimeric interface, but when the virus is endocytosed, the endosome 
becomes acidified, and this low pH triggers HA to undergo an irreversible 
conformation change termed “activation” (Figure 2). A loop to helix transition in 
the HA2 subunit, expels the fusion peptide from the hydrophobic trimer interior, 
repositioning it at the membrane distal end of the protein.5 It is known that the 
fusion peptide is necessary for fusion of the viral and endosomal membranes, but 
it is unknown which membrane it inserts into.6 The most accepted model, 
however, proposes that it inserts into the host membrane (Figure 3).  
 
 
                         
Figure 2: Hemagglutinin Trimer Cartoon. 
Adapted from Eckert and Kim,  Annu. Rev. Biochem., 70: 777-810, 2001. 
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 Figure 3: Hemagglutinin-
Harrison, Stephen C., Nature Structural Biology 15 (2008), 690
 
 
 
Cell-Based Detection Assay to Identify Novel Activators
 
 Previous work established a cell
novel HA mutants that activated at both lower an
First, it was established the fusion peptide could be utilized as a detection tag by 
replacing amino acids 11-20 with a c
the fusion peptide, and consequently detection tag, remain buried in the trimer 
interface at neutral pH. In this conformation, staining 
c-myc epitope is unsuccessful, as the antibody has no opportunity to bind. 
incubating cells at 5 minutes at a low pH, however, the fusion peptide is exposed 
and amenable to labeling with 
 Figure 4 verifies this assay. The x
trimers on the cell surface, while the y
exposed c-myc epitope, which corresponds to activated HA trimers.  
pH 7, 31% of cells are expressing inactivated HA, however, 0% of the HA is 
activated. At pH 5.4, one can begin to see the activation of HA, as 2
are expressing inactivated HA, but a small 4% of cells express activated HA. At 
pH 5.0, almost all of the HA has been activated, as only 3% of cells express 
inactivated HA, while 25% of cells are expressing activated HA. Of significant 
note, no cells are expressing both inactivated and activated HA, as these cells 
would be detected in the upper right quadrant. 
Mediated Membrane Fusion. 
-698.  
-based HA functional assay that identified 
d higher pH than the wild
-myc epitope sequence. With this construct, 
with antibody specific to the
the c-myc epitope specific antibody.  
-axis quantifies the presence of HA 
-axis quantifies the presence of the 
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Figure 4: Verification of c-myc Detection Tag for Activation 
Lee, J.H. Engineering and Characterization of Influenza Hemagglutinin 
Properties in Mammalian System. PhD Thesis, 2007. 
 
 
 This assay was then extended to identify mutants with novel activation pH. 
Wild-type HA activates at pH 5.2, so it was desirable to find mutants that were 
comparatively stabilized (pH 4.8) and destabilized (pH 5.6 and 6.0). First a 
combinatorial library was created via random mutation of the protein sequence. 
Mutated sequences were then ligated into the retroviral vector pLNCX2. These 
plasmids were then used to transfect EcoPack 2-293 cells. Virus was collected 
and used to retrovirally transduce 3T3 cells. With this system, each cell is 
expressing only one mutant, and thus can be assayed using the cell-based c-
myc assay described above. Secondly, virus rescue can be employed to recover 
DNA from desired clone.  
 The library was screened for higher mutants by first incubating at the 
desired pH. These higher pH values are sufficient for activating mutants with 
novel phenotypes without activating the wild-type HA. The library was then 
labeled with anti-cmyc antibodies. Only novel activators will have an exposed 
epitope, and therefore will be the only cells labeled.  The library can then be 
screened for novel activators using Fluorescence Activated Cell Sorting (Figure 
log(trimeric HA) 
log
(ex
pos
ed  
c-
my
c) 
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5). HC2 is an antibody specific for HA trimers in any conformation, thus 
quantifying overall HA expression, and as previously mentioned, anti-c-myc, 
recognizes the engineered c-myc tag on the fusion peptide, quantifying only 
activated HA. In the naïve library, only 6% of cells displayed novel activating 
phenotypes at pH 5.6, but after three rounds of FACS sorting, this population 
was enriched to 96%. Similarly, only 5% of the naïve library displayed activation 
at pH 6.0, but was enriched to 88% after three rounds of FACS sorting.   
 
Figure 5: High pH Mutants Pre- and Post-Sort. 
Lee, J.H. Engineering and Characterization of Influenza Hemagglutinin 
Properties in Mammalian System. PhD Thesis, 2007. 
 
 
Low pH novel activators required more processing steps. Incubating the 
library at pH 4.8 would not only activate the desired low pH activators, but also 
the undesired wild-type activators and high pH activators. First, the naïve library 
was incubated at pH 5.2 for 5 minutes to activate wild-type activators as well as 
high pH activators. Thermolysin, an enzyme that preferentially cleaves 
hydrophobic residues, was then used to cleave the exposed fusion peptides. 
Now that all clones activating at pH 5.2 or above were essentially rendered 
inactive, the library was pulsed at the desired pH of 4.8. At this point, the process 
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lo
g
(e
x
p
o
se
d
		
m
y
c)
	
 9 
becomes similar to before, and three rounds of FACS isolated the desired low pH 
mutants (Figure 6). 
 
Figure 6: Low pH Mutant Schematic.  
Lee, J.H. Engineering and Characterization of Influenza Hemagglutinin 
Properties in Mammalian System. PhD Thesis, 2007. 
 
Mutants recovered from the sorting process were characterized to verify 
that they do in fact possess a novel activating phenotype, and sequencing 
revealed mutated residues7(Figure 7).  
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Figure 7: Summary Table of Directed Evolution Mutants 
 
 
Characterization of Single Mutants 
 
 In order to delve further into the HA structure-function relationship, the 
directed evolution mutants were further dissected to evaluate which mutations 
were responsible for the novel phenotypes. A single amino acid mutant was 
constructed for each of the mutations in the directed evolution mutant matrix. 
Each of these clones was then characterized for its activation pH.  The c-myc 
detection tag system was not used for this study. Instead, a conformation specific 
antibody, HC58, was used. HC58 binds only to pre-activated HA trimers. 
Therefore, loss of HC58 binding corresponds to HA activation.  
It was found that mutations Y106F, E199Q, and S236K were not unique 
mutations and were in fact inherent in the wild-type sequence used to construct 
the naïve library. These mutants were not characterized in this study for this 
reason and from this point on wild-type refers to the sequence containing these 
three mutations.  
 
 
 
 
 
 
 
 
 
Clones Activation pH Mutations 
HA3.2.1 5.6 
  Y106      E199Q      W243S     
HA3.2.2 5.6 
     G166D         W243S  L407A   
HA3.2.3 5.6 
   G142D  G166D    Y218H          
HA3.2.4 5.6 
     G166D     S236K         
HA3.2.5 5.6 
 I96M      V178G       W243S  L407A S429P  
HA3.3.1 6 
     G166D   E199Q  S236K     G365C    
HA3.3.2 6 
  Y106   G166D   E199Q  S236K G237R    G365C    
HA3.3.3 6 
        E199Q  S236K G237R    G365C    
HA3.4.1 4.8 D93S                  E462Q 
HA3.4.2 4.8 
    Y155F  A168V      D240Y D247N      
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Materials and Methods 
 
Site-Directed Mutagenesis 
 A/FPV/Rostock/34 was used as the template sequence. Single amino acid 
mutations were created in the wild-type HA DNA using the Stratagene Site-
Directed Mutagenesis Protocol. The protocol was followed except Phusion 
polymerase was used instead of PfuTurbo as listed, and PfuUltra was used as 
reaction buffer. Mutant colonies were screened for the correct mutation via 
sequencing.  
 
Development of Stable Cell Lines 
 HEK 293 cells were utilized in the creation of a retrovirally transduced 
stable cell line expressing each single mutant individually. Amphopack HEK 293 
cells were transfected with the desired point mutant DNA and virus was 
harvested two days later. Then, this harvested virus was used to transfect 
EcoPack HEK 293 cells. Two days post-transfection, cells are sub-cultured into 
media containing 200ug/ml of the antibiotic g418. Selection for cells containing 
the mutant DNA continues for approximately two weeks (Figure 7).  
 
 
Figure 7: Schematic of the Development of Stable Cell Lines. 
 
pH Pulse Experiment 
 Cells are first washed with 5ml of PBS. Then, 0.4ml of 0.05% Trypsin-
EDTA is added to each T-25 flask and cells are incubated at 37°C for 
approximately 10 minutes, or until cells have been almost entirely released from 
the flask surface. Cells are then aliquoted into 1ml Eppendorf tubes (4 aliquots 
per T25 flask). Cells are then spun down for 5 minutes at 1,000xg and 
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resuspended in 500ul of  pH 7.4 PBS+0.1%BSA. This wash step is repeated. 
Cells are then spun down once more and all remaining supernatant removed via 
pipette.  
 Each aliquot is then assigned a pH within the pH range being evaluated 
for that particular mutant, i.e.  4.6 – 5.4 for low pH mutants, or 5.2 – 6.2 for high 
pH mutants. Often this range will be adjusted after preliminary data reveals the 
effect of the mutation on the activation pH. Each aliquot is resuspended in 750ul 
of the designated pH buffer (See appendix for composition). Cells are incubated 
for 4 minutes at room temperature and then spun down for 1 minute at 1,000xg. 
Supernatant is quickly dumped into waste and then the cells are neutralized with 
750ul of pH 7.4 PBS + 0.1%BSA. Cells are spun down again for 4 minutes at 
1,000xg. Two aliquots are also reserved as controls and were resuspended in 
the neutral pH 7.4 PBS+0.1%BSA buffer rather than the pH buffer.  
 Supernatant is removed entirely with a pipette and cells are resuspended 
in a small volume of pH 7.4 PBS+0.1%BSA. In many of the first experiments, a 
100ul resuspension was used, but then reduced to 50ul for later experiments to 
conserve antibody. Cells are then labeled with a primary antibody. All cells 
“pulsed” with a pH buffer were labeled 1:100 with HC58, which binds to 
inactivated HA trimers. One control aliquot was labeled with HC58 and one with 
HC2, which will bind HA trimers in any conformation thus quantifying level of HA 
expression.   Cells are incubated with the primary antibody for one hour on ice.  
 After primary antibody labeling, cells are spun down at 1,000xg for 5 
minutes. Supernatant is removed with a pipette and cells are resuspended in 
500ul of pH 7.4 PBS+0.1%BSA. Cells are spun down one more time at 1,000xg 
for 5 minutes and supernatant removed completely. Cells are then resuspended 
in 100ul of a 1:100 dilution of the fluorescent secondary antibody, AF488 goat-
anti-mouse, in pH 7.4 PBS+0.1%BSA. Cells are incubated on ice, covered for 45 
minutes. After incubation, cells are spun down at 1,000xg for 5 minutes, 
resuspended in 750ul of pH 7.4 PBS+0.1%BSA, spun down again, and 
resuspended in a final volume of 500ul of pH 7.4 PBS+0.1%BSA. Each aliquot is 
then run on the flow cytometer according to standard lab procedures.  
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Quantification of Activation pH 
 Flow cytometry data was analyzed using FloJo software to obtain median 
fluorescent data for each data sample. Each mutant’s activation pH was then 
extracted from this median fluorescent data using Prism by graphpad. 
 
 
Results 
 
 The calculated activation pHs of the characterized clones are summarized 
in Table 1. The dose-repsonse curves of two mutants, D247N and G365C, are 
shown in comparison with that of wild-type for reference (Figure 8). Single 
mutations D247N and S429P produced stabilizing effects, activating at pH 4.83 
and 5.06, respectively. Mutations I96M and G237R were found to be moderately 
destabilizing, activating at pH 5.79 and 5.77, respectively. Mutation G365C is 
significantly destabilizing, activating at pH 6.09. These five residues, I96M, 
D247N, S429P, G237R, and G365C, are key residues for the activation of HA 
(Figure 9). 
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Table 1: Summary Table of Single Mutant Activation pH. 
 
   
Figure 8: Dose-Response Curve for D247N, wild-type, and G365C. 
 
 
G365C	
WT	
D247N	
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Figure 9: Structural Location of Key Residues. 
A) Side view of HA trimer B) Top down view of HA trimer 
 
 
Conclusions 
 
 It is clear from the characterization of these single mutations that I96M, 
D247N, S429P, G237R, and G365C, are key residues that can individually alter 
the activation pH of HA. The structure-function relationship has not been fully 
elucidated, however.  
 D247N as seen in the blown up figure, is in close proximity to a negatively 
charged glutamic acid. Replacing the negatively charged aspartic acid with a 
neutral asparagine likely eliminates this electrostatic charge, explaining the 
stabilizing effect of the D247N mutation. Experiments are currently planned to 
characterize the D247R mutation, which would replace the negatively charged 
aspartic acid with a positively charged asparagine, potentially stabilizing HA even 
further than D247N.  
B	A	 G237R	
D247N	
I96M	
S429P	
G365C	
Disulfide	
Bond	
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 As shown in the blown up figure, G365C is in close proximity to the 
disulfide bond, which stabilizes the HA1-HA2 subunits. It is hypothesized that this 
cysteine mutation, which is located on the HA2 subunit, is disrupting this disulfide 
bond, and creating a disulfide bond of its own with the HA1 residue. This could 
perhaps explain the dose-response curve for G365C, which as seen in that 
figure, does not transition as sharply as wild-type, or D247N. A mixture of the 
native disulfide bond and this new G365C disulfide bond could result in this 
intermediate state. Experiments are not currently underway to evaluate this 
hypothesis, but can easily be done by mutating the G365C mutant at the HA2 
cysteine residue and characterizing the activation.  If this mutant is functional and 
activates at a high pH, our hypothesis would be confirmed 
 The other mutations, I96M, S429P, and G237R are less obvious in their 
structural reasoning for altered activation.  Further analysis, likely utilizing 
simulation, will need to be done to formulate hypotheses regarding these 
mutations.  
 It is interesting to note that the altered phenotype of most of the mutants 
selected via directed evolution can be attributed to a single amino acid mutation. 
The exception is mutant HA3.2.5, which appears to activate at the higher pH of 
5.6 through a combinatorial effect of two mutations. I96M confers a slightly 
destabilizing effect, but is counterbalanced by the stabilizing effect of S429P. 
These mutations have only been characterized individually, however, and a dual 
mutant should be characterized for confirmation.  
 At this moment no single mutation that confers altered phenotype for the 
remainder of the directed evolution mutants selected at pH 5.6. Some of these 
mutations are not entirely characterized, lacking one or two data sets for 
statistical significance, or contain “messy” data that may require additional 
experiments to confirm the calculated activation pH. It is also likely that no single 
mutation is leading to these altered phenotypes and that dual mutations will need 
to be characterized to elucidate the true cause. The repeated presence of 
mutation D166G, however, does lead one to hypothesize that it is producing a 
destabilized effect. The current calculated activation pH does in fact show a 
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transition at pH 5.5, which is destabilized, but not statistically different from the 
wild type transition of pH 4.5. 
To further understand the structure-function relationship between these 
key residues, it would be interesting to perform a search on known influenza 
sequences to determine if these mutations have occurred naturally. If any of 
these mutations were found in naturally occurring strains, it would be informative 
to know if that strain saw any marked difference in properties like virulence and 
host range.  
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